| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/07/2013 | WO2013001505A3 Sulphonamide derivatives of alicyclic amines for the treatment of central nervous system diseases |
| 03/07/2013 | WO2012160333A3 Recombinant yeast expressing human h- ferritin |
| 03/07/2013 | WO2012144938A3 Composition of protectors of acute and chronic hepatic encephalopathy and method for treating acute and chronic hepatic encephalopathy |
| 03/07/2013 | WO2012144854A3 Novel uses of licochalcone a |
| 03/07/2013 | WO2012141553A3 Stabilizing composition for tetrahydrobiopterin, and method for analyzing tetrahydrobiopterin using same |
| 03/07/2013 | WO2012102562A3 Composition containing novel 4-ｏ-methylhonokiol derivative as active ingredient for treatment of dementia |
| 03/07/2013 | WO2011156331A9 Human neural progenitor derived dopaminergic progenitors and neurons |
| 03/07/2013 | US20130061339 Method of diagnosing trichotillomania and similar disorders in humans and rodents |
| 03/07/2013 | US20130060039 Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists |
| 03/07/2013 | US20130059917 Modified release dosage form comprising desvenlafaxine or salts thereof |
| 03/07/2013 | US20130059910 Conjugates comprising a gaba- or glycine compound, pharmaceutical compositions and combinations thereof as well as their use in treating cns disorders |
| 03/07/2013 | US20130059902 Methods and compositions useful in treatment of diseases or conditions related to repeat expansion |
| 03/07/2013 | US20130059900 Crystal form i of (s)-4-hydroxy-2-oxo-1-pyrrolidine acetamide, preparing method and use thereof |
| 03/07/2013 | US20130059899 Methods of identifying modulators of gpr17 |
| 03/07/2013 | US20130059897 Rapid release irbesartan-containing pharmaceutical composition |
| 03/07/2013 | US20130059891 Substituted n-heterocycloalkyl bipyrrolidinylphenyl amide derivatives, preparation and therapeutic use thereof |
| 03/07/2013 | US20130059888 Medicament for prophylactic and/or therapeutic treatment of alzheimer-type dementia |
| 03/07/2013 | US20130059887 Substituted pyridoxine-lactam carboxylate salts |
| 03/07/2013 | US20130059883 Compounds and methods |
| 03/07/2013 | US20130059876 Liquid nasal spray containing low-dose naltrexone |
| 03/07/2013 | US20130059874 Substituted n-phenyl spirolactam bipyrrolidines, preparation and therapeutic use thereof |
| 03/07/2013 | US20130059871 Pyrimidine derivatives for the treatment of amyloid-related diseases |
| 03/07/2013 | US20130059870 Use of myeloperoxidase (mpo) inhibitors or pharmaceutically acceptable salts thereof to treat multiple sysyem atrophy (msa) 938 |
| 03/07/2013 | US20130059866 Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma |
| 03/07/2013 | US20130059864 Inhibiting neurotransmitter reuptake |
| 03/07/2013 | US20130059863 Substituted n-heteroaryl spirolactam bipyrrolidines, preparation and therapeutic use thereof |
| 03/07/2013 | US20130059860 Naphthalene carboxamide m1 receptor positive allosteric modulators |
| 03/07/2013 | US20130059850 Aza-indole derivatives useful as modulators of faah |
| 03/07/2013 | US20130059848 Cannabinoid-2 agonists |
| 03/07/2013 | US20130059840 Sulfonamido pyrrolidine compounds which inhibit beta-secretase activity and methods of use thereof |
| 03/07/2013 | US20130059838 Substituted n-heteroaryl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof |
| 03/07/2013 | US20130059835 Heterocyclylamines as pi3k inhibitors |
| 03/07/2013 | US20130059834 Pyrrolopyrazine kinase inhibitors |
| 03/07/2013 | US20130059833 Pde10 modulators |
| 03/07/2013 | US20130059829 Treatment of central nervous system disorders |
| 03/07/2013 | US20130059824 Methods for treating mild cognitive impairment |
| 03/07/2013 | US20130059821 Bicyclic aryl sphingosine 1-phosphate analogs |
| 03/07/2013 | US20130059819 Inhibitors of fatty acid amide hydrolase |
| 03/07/2013 | US20130059816 Compositions and methods for treatment of autoimmune and other disease |
| 03/07/2013 | US20130059804 Synthesis of compounds useful as modulators of amyloid-beta production |
| 03/07/2013 | US20130059801 Fatty acid amides, compositions and methods of use |
| 03/07/2013 | US20130059798 Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway |
| 03/07/2013 | US20130059788 Prodomain modulators of adam 10 |
| 03/07/2013 | US20130059787 Methods of using human protein kinase c delta viii as a biomarker |
| 03/07/2013 | US20130059770 Polypeptides |
| 03/07/2013 | US20130059019 Methods and compositions for treating inflammation of skin |
| 03/07/2013 | US20130059010 Alcohol-resistant oral pharmaceutical form |
| 03/07/2013 | US20130059007 Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes |
| 03/07/2013 | US20130059005 Bupropion hydrobromide polymorphs |
| 03/07/2013 | US20130059004 Oral drug delivery system |
| 03/07/2013 | US20130059003 Sustained release donepezil formulations |
| 03/07/2013 | US20130059001 Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same |
| 03/07/2013 | US20130058998 Encapsulated n-acetylmannosamine or n-acetylneuraminic acid to increase sialylation |
| 03/07/2013 | US20130058994 Liposomes containing oligopeptide fragments of myelin basic protein, a pharmaceutical composition and a method for treatment of multiple sclerosis |
| 03/07/2013 | US20130058982 Method of treating Alzheimer's disease |
| 03/07/2013 | US20130058981 Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia |
| 03/07/2013 | US20130058972 Methods for regulating complement cascade proteins using astrovirus coat protein and derivatives thereof |
| 03/07/2013 | US20130058955 Anti-polyubiquitin antibodies and methods of use |
| 03/07/2013 | US20130058946 Seizure and Migraine Treatments using Denosumab |
| 03/07/2013 | US20130058942 Human beta-adrenergic receptor kinase polypeptide and methods |
| 03/07/2013 | US20130058939 Treatment of neurological or neurodegenerative disorders |
| 03/07/2013 | US20130058919 Optimized Fc Variants and Methods for their Generation |
| 03/07/2013 | US20130058918 Isolation and use of a new type of glial cell with neurotoxic potential |
| 03/07/2013 | US20130058917 Antibody composition obtained by fractionation of plasma immunoglobulins affinity chromatography on a sambucus nigra affinity column |
| 03/07/2013 | US20130058915 Methods and compositions for treatment of angelman syndrome and autism spectrum disorders |
| 03/07/2013 | US20130058893 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 03/07/2013 | US20130058884 Herbal oil which is used in hair care and in massage and which is used in treatment of hair loss, hairlessness, and burns |
| 03/07/2013 | US20130058873 P97 fragments with transfer activity |
| 03/07/2013 | US20130058871 Method and system for mapping synaptic connectivity using light microscopy |
| 03/07/2013 | US20130058869 Prevention And Treatment Of Amyloidogenic Disease |
| 03/07/2013 | US20130058868 Method for the treatment of t cell mediated conditions by depletion of icos-positive cells in vivo |
| 03/07/2013 | DE10213051B4 Substituierte 4-Aminocyclohexanole Substituted 4-aminocyclohexanols |
| 03/07/2013 | CA2847336A1 Glycosylated polypeptide and drug composition containing said polypeptide |
| 03/07/2013 | CA2847334A1 Glycosylated polypeptide and drug composition containing said polypeptide |
| 03/07/2013 | CA2847247A1 Novel benzodiazepinones as modulators of metabotropic glutamate receptor functions and neurological uses thereof |
| 03/07/2013 | CA2847235A1 Treatments involving eslicarbazepine acetate or eslicarbazepine |
| 03/07/2013 | CA2847066A1 Novel crystal form |
| 03/07/2013 | CA2847017A1 Selective and reversible inhibitors of ubiquitin specific protease 7 |
| 03/07/2013 | CA2846463A1 Pyrimidines as sodium channel blockers |
| 03/07/2013 | CA2844521A1 Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| 03/07/2013 | CA2844128A1 Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| 03/07/2013 | CA2843514A1 (thieno[2,3-b][1,5]benzoxazepin-4-yl)piperazin-1-yl compounds as dual activity h1 inverse agonists/5-ht2a antagonists |
| 03/07/2013 | CA2842133A1 Pharmaceutical composition for use in the treatment of a neurodegenerative disease |
| 03/06/2013 | EP2565195A1 Peripheral opioid receptor and antagonists and uses thereof |
| 03/06/2013 | EP2565194A1 IMIDAZO[1,2-a]PYRIDINE DERIVATIVE |
| 03/06/2013 | EP2565186A1 Selective and reversible inhibitors of ubiquitin specific protease 7 |
| 03/06/2013 | EP2565184A1 Therapeutic agent and preventative agent for alzheimer's disease |
| 03/06/2013 | EP2565183A1 Glycine transporter-1 inhibitors |
| 03/06/2013 | EP2565182A1 Novel amide derivative and use thereof as medicine |
| 03/06/2013 | EP2564873A1 Skin irritation suppressant and transdermal preparation |
| 03/06/2013 | EP2564872A1 Combination of mazindol in the treatment of attention-deficit/hyperactivity disorder |
| 03/06/2013 | EP2564871A1 Therapeutic Agent for Migraine |
| 03/06/2013 | EP2564851A2 Agent exhibiting the properties of a cognitive function promoter (embodiments) |
| 03/06/2013 | EP2564849A1 Prophylactic or therapeutic agent for diseases associated with pains in urinary organs |
| 03/06/2013 | EP2564848A1 Transdermally absorbable donepezil-containing preparation |
| 03/06/2013 | EP2564843A1 Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
| 03/06/2013 | EP2564842A1 Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
| 03/06/2013 | EP2564838A1 Enteric tablet |
| 03/06/2013 | EP2564837A1 Enteric tablet |
| 03/06/2013 | EP2563804A2 Preparation of polypeptides and salts thereof |